How many shares of BMRN does BNP PARIBAS FINANCIAL MARKETS own?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 490,189 shares of BMRN (BIOMARIN PHARMACEUTICAL INC).

What is BNP PARIBAS FINANCIAL MARKETS's BMRN position worth?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's BMRN position is worth $28M.

Is BNP PARIBAS FINANCIAL MARKETS buying or selling BMRN?

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS increased their BMRN position (+9.2% change in shares).

When did BNP PARIBAS FINANCIAL MARKETS first buy BMRN?

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in BMRN in 2018-Q4. They have held the position across 31 quarters.

Back to

BNP PARIBAS FINANCIAL MARKETS

BMRN
31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BIOMARIN PHARMACEUTICAL INC

Current Value

$28M

Current Shares

490,189

Total Value Change

+$24.2M

Total Shares Change

+445,520

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	490,189	+9.2%	$28M	0.0%	$57.22	31
2026-Q1	Increased	448,768	+2.9%	$25.4M	0.0%	$58.53	29
2025-Q4	Increased	436,024	+22.9%	$25.9M	0.0%	$58.99	35
2025-Q3	Increased	354,689	+3.3%	$19.2M	0.0%	$54.02	29
2025-Q2	Increased	343,279	+162.5%	$18.9M	0.0%	$55.17	46
2025-Q1	Decreased	130,777	-11.1%	$9.2M	0.0%	$71.44	0
2024-Q4	Decreased	147,137	-2.1%	$9.7M	0.0%	$65.45	0
2024-Q3	Increased	150,364	+12.8%	$10.6M	0.0%	$70.58	31
2024-Q2	Decreased	133,354	-37.2%	$11M	0.0%	$82.33	0
2024-Q1	Decreased	212,437	-37.6%	$18.6M	0.0%	$87.34	0
2023-Q4	Increased	340,231	+91.7%	$32.8M	0.0%	$96.42	46
2023-Q3	Decreased	177,463	-21.5%	$15.7M	0.0%	$88.48	0
2023-Q2	Decreased	226,107	-5.9%	$19.6M	0.0%	$88.93	0
2023-Q1	Increased	240,367	+3.7%	$23.4M	0.0%	$95.29	30
2022-Q4	New	231,837	-	$24M	0.0%	$103.49	40
2022-Q3	Exited	0	-100.0%	$0	0.0%	$85.06	0
2022-Q2	Increased	195,856	+4.2%	$16.2M	0.0%	$83.92	29
2022-Q1	Increased	187,988	+40.9%	$14.5M	0.0%	$77.89	37
2021-Q4	Increased	133,432	+80.8%	$11.8M	0.0%	$89.08	43
2021-Q3	Increased	73,811	+16.0%	$5.7B	0.0%	$76.79	37
2021-Q2	Decreased	63,619	-12.6%	$5.3M	0.0%	$83.46	0
2021-Q1	Decreased	72,803	-50.5%	$5.5M	0.0%	$74.96	0
2020-Q4	Decreased	147,217	-13.3%	$12.9M	0.0%	$86.96	0
2020-Q3	Decreased	169,883	-21.1%	$12.9M	0.0%	$76.00	0
2020-Q2	Increased	215,318	+47.6%	$26.6M	0.0%	$122.18	39
2020-Q1	Decreased	145,828	-13.2%	$12.3M	0.0%	$82.49	0
2019-Q4	Increased	168,085	+67.8%	$14.2M	0.0%	$84.59	41
2019-Q3	Decreased	100,166	-32.4%	$6.8M	0.0%	$68.31	0
2019-Q2	Increased	148,115	+74.5%	$12.7M	0.0%	$85.65	42
2019-Q1	Increased	84,856	+90.0%	$7.5M	0.0%	$88.83	43
2018-Q4	New	44,669	-	$3.8M	0.0%	$83.60	37

Other major holders of BMRN: Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

BMRN31 quarters

BMRN
31 quarters